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Experiments—A Focus on Pragmatic Approaches in HealthStated preference techniques including the discrete choice
experiment (DCE) provide a fundamental and increasingly popu-
lar method to evaluate the trade-offs people are willing to make
between different characteristics of health and health care [1].
The development of discrete choice studies is an iterative process
involving a number of dependent stages [2]. As a consequence,
the implementation of these studies demands a range of diverse
skills, spanning both qualitative and quantitative methodologies.
Perhaps the most elusive of these skills for many researchers and
practitioners has been experimental design, that is, ‘‘the process
of generating specific combinations of attributes and levels that
respondents evaluate in choice questions’’ [3].
The frequent application of fractional factorial designs in
health (100% of DCE studies published in health between 2001
and 2008 used fractional factorial designs [1]) reinforces the
integral role experimental design plays in every DCE study. The
research frontier in experimental design, as with many other
areas of choice modeling, is evolving quickly. The development of
experimental design methods has taken place not only in health
but also to a large extent in fields outside a health context.
Consequently, researchers and practitioners using stated prefer-
ence methods are challenged to keep abreast of rapidly changing
goalposts and an ever-developing array of possible experimental
design approaches.
This issue of Value in Health sees the publication of a much
anticipated report from the ISPOR Conjoint Analysis Experimen-
tal Design Good Research Practices Task Force on Constructing
Experimental Designs for Discrete-Choice Experiments [3]. As
highlighted by the authors of the report [3], the ‘‘significant
advances’’ in experimental design have been accompanied by
‘‘significant confusion’’ and inadequate reporting of experimental
design in stated preference studies. While many studies under-
take and report experimental design approaches appropriately,
one recent review found that 37% of the DCE studies published in
health between 2001 and 2008 did not provide sufficient detail to
discern the source of an experimental design and 28% did not
clearly report the method used to create choice sets [1]. There
appears to be a clear need then for further guidance and under-
standing of what constitutes ‘‘best practice’’ for experimental
design, and this seems to have been a motivator for the establish-
ment of the Task Force and the subsequent report [3].
While the authors of the report perhaps wisely do not attempt
to establish standards or recommendations for experimental
design, they have engaged widely with the research and practi-
tioner community who use stated preference methods. The
result is a succinct summary covering a comprehensive range
of design approaches with a practical focus, which aims to ‘‘assist
researchers specifically in evaluating alternative approaches toexperimental design.’’ The guidance provided is specific to the
traditional DCE stated preference format, which has been the
most commonly used approach in health to date [4]; however,
the authors highlight that much of the report is also relevant to
some other stated preference formats.
After an introduction, the report summarizes the underlying
theory and concepts of experimental design. Here, the authors
focus strongly on the importance of identification, and the
inextricable links and trade-offs between statistical and response
efficiency. The need for flexibility in design approaches is at least
as (or perhaps more) paramount in health as in other fields in
which DCE studies are used. All design approaches can cater to
the situation in which a basic generic choice with no constraints
is all that is required. However, to provide a realistic and mean-
ingful choice for respondents, it is sometimes necessary to
consider a more complex design approach. Examples of cases
in which this arises are detailed by the report and include when
an opt-out or status quo alternative may be required, when
attribute levels need to be specific to the alternative on offer, or
when a particular combination of attribute levels may need to be
avoided. The authors take a pragmatic approach throughout the
report, identifying and discussing challenges to statistical and
response efficiency that are often seen in health applications.
In doing so, they achieve their aim to ‘‘provide a guide for
choosing an approach that is appropriate for a particular study’’
(emphasis added).
The report also highlights the challenges arising from the
relatively small sample sizes that are frequently used in health
and health care [3]. Sampling frames particularly for studies
involving patients or decision makers can often be limited [3,4],
making large samples or sample extension beyond reach. Argu-
ably, sample sizes are limited to a greater extent in health than in
many of the other fields, in which preference populations may
focus, for example, on the general public or transport users
(e.g., [5,6])—a less constrained sampling frame. As highlighted
by the report authors [3], in health perhaps more so than in many
other fields, a consideration of design efficiency in addition to
identification is particularly pertinent. Awareness of efficient
design approaches has increased in recent years [1], emphasizing
the need for a broader understanding of these design principles.
The authors go on to compare a range of different approaches
to design, in terms of their accessibility to researchers, under-
lying assumptions, and flexibility to specific requirements such
as the inclusion of interaction effects or design constraints [3].
This perhaps represents the most important contribution of the
report, particularly for the more novice researcher using DCE
methods. The array of design approaches now available and
in particular the availability of design software supports the
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than was previously possible, and puts these designs within
the reach of researchers without substantial experimental
design experience. In contrasting the comparative merits of these
approaches, the authors support the researcher to choose an
approach appropriate to both their study and their abilities.
The European Medicines Agency and, to a lesser extent, the
Food and Drug Administration recently have advocated a more
prominent role for patients’ assessments of the risks and benefits
of drug and device interventions in the regulatory process [7,8].
DCEs are an excellent vehicle for quantifying patient views,
and the increasing number of DCE studies in health has been
commensurate with the increased attention to patient prefer-
ences by regulatory bodies and others. However, the acceptance
of DCEs within the regulatory process requires the consistent use
of high-quality research methods. High quality does not neces-
sarily mean ‘‘the most sophisticated’’ approach, and it certainly
does not imply a single, one-size-fits-all approach. Rather, the
production of high-quality research requires an appreciation and
an understanding of the strengths and weaknesses of alternative
approaches and the thoughtful application of an appropriate
approach to a specific problem. As noted above, the authors have
provided a framework that allows researchers to do exactly that.
Few would disagree that an understanding of experimental
design is crucial for those using stated preference methods. So, as
the saying goes, ‘‘garbage in, garbage out.’’ Choice data elicited from
a DCE study are only as good as the underlying experimental
design. If the design is poor, so is the capacity to make inferences
from the choice data. How timely then to have guidance produced
in consultation with the community of researchers and practi-
tioners using stated preference methods, which provides a sum-
mary and comparison of contemporary approaches to experimental
design. The authors state, ‘‘We create designs that we know are not
perfect, but these designs are good enough to identify the para-
meters of interest under particular simplifying assumptions’’ [3].
While ‘‘perfect’’ designs may be unachievable in many health DCE
applications, this report takes researchers and practitioners a step
closer to at least achieving the best design that is pragmatically
feasible and reporting their approach with clarity and precision.
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